161 related articles for article (PubMed ID: 23616161)
21. Varicella-zoster virus myelitis: an expanding spectrum.
Gilden DH; Beinlich BR; Rubinstien EM; Stommel E; Swenson R; Rubinstein D; Mahalingam R
Neurology; 1994 Oct; 44(10):1818-23. PubMed ID: 7936229
[TBL] [Abstract][Full Text] [Related]
22. When Zoster Becomes Monster: A Rare Case Report of Herpes Zoster Myelitis.
Sagar P; Dindigal RN; Kulkarni A; Sinha S
Neurol India; 2023; 71(2):372-374. PubMed ID: 37148082
[No Abstract] [Full Text] [Related]
23. Disease reactivation after switching from natalizumab to daclizumab.
Uphaus T; Oberwittler C; Groppa S; Zipp F; Bittner S
J Neurol; 2017 Dec; 264(12):2491-2494. PubMed ID: 28975400
[TBL] [Abstract][Full Text] [Related]
24. [Varicella-Zoster Myelitis with Medullary Infarction: A Case Report].
Hoshino M; Itoh A; Shimizu T; Akiyama H; Yamano Y
Brain Nerve; 2023 Mar; 75(3):269-273. PubMed ID: 36890763
[TBL] [Abstract][Full Text] [Related]
25. Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients.
Matko S; Akgün K; Tonn T; Ziemssen T; Odendahl M
Mult Scler Relat Disord; 2020 Feb; 38():101859. PubMed ID: 31855843
[TBL] [Abstract][Full Text] [Related]
26. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.
Ma C; Walters B; Fedorak RN
World J Gastroenterol; 2013 Jun; 19(21):3347-51. PubMed ID: 23745038
[TBL] [Abstract][Full Text] [Related]
27. Varicella-zoster virus.
Arvin AM
Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
[TBL] [Abstract][Full Text] [Related]
28. Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients.
van Kempen ZLE; van Rossum JA; Hoogervorst E; Strijbis E; Toorop A; Bosscha MI; Frequin S; Dam-van Loon NT; Wattjes MP; Murk JL; Killestein J; Uitdehaag BMJ
Mult Scler Relat Disord; 2021 May; 50():102838. PubMed ID: 33609925
[TBL] [Abstract][Full Text] [Related]
29. Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis.
Nakamura M; Itani K; Miyake K; Kunieda T; Kaneko S; Kusaka H
Intern Med; 2017; 56(2):211-214. PubMed ID: 28090055
[TBL] [Abstract][Full Text] [Related]
30. [Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive varicella-zoster virus myelitis presenting as longitudinally extensive transverse myelitis: a case report].
Shiga Y; Kamimura T; Shimoe Y; Takahashi T; Kaneko K; Kuriyama M
Rinsho Shinkeigaku; 2017 Oct; 57(10):579-583. PubMed ID: 28954973
[TBL] [Abstract][Full Text] [Related]
31. Fatal acute varicella-zoster virus hemorrhagic meningomyelitis with necrotizing vasculitis in an HIV-infected patient.
Chang CC; McLean C; Vujovic O; Jenney AJ; Short M; Lyon S; Storey E; Lewin SR
Clin Infect Dis; 2009 Feb; 48(3):372-3. PubMed ID: 19128163
[No Abstract] [Full Text] [Related]
32. A case of herpes zoster myelitis: positive magnetic resonance imaging finding.
Hwang YM; Lee BI; Chung JW; Ahn JH; Kim KW; Kim DI
Eur Neurol; 1991; 31(3):164-7. PubMed ID: 1646111
[TBL] [Abstract][Full Text] [Related]
33. [A patient with myelitis of varicella-zoster without skin lesions--diagnostic value of virus antibody index in CSF].
Inukai A; Katayama T; Kenjo M; Yokokawa Y; Aiba I; Saito Y
Rinsho Shinkeigaku; 2010 Sep; 50(9):634-40. PubMed ID: 20960928
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature.
Paybast S; Sahraian MA; Nahayati MA; Habibi MA; Shahmohammadi S; Navardi S
Mult Scler Relat Disord; 2023 Sep; 77():104793. PubMed ID: 37413854
[TBL] [Abstract][Full Text] [Related]
35. Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Haller S; Barkhof F; Wattjes MP; Lalive PH
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):475-6. PubMed ID: 25246642
[No Abstract] [Full Text] [Related]
36. Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab.
Rapisarda L; Valentino P; Barone S; Torti C; La Gamba V; Fortunato F; Sammarra I; Gambardella A
Clin Immunol; 2021 Feb; 223():108554. PubMed ID: 32777270
[TBL] [Abstract][Full Text] [Related]
37. [The differential diagnosis of amyotrophic lateral sclerosis and subacute herpes virus myelitis].
Levitsky GN; Zavalishin EE; Chub RV; Morozova EA; Serkov SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):110-113. PubMed ID: 28091511
[TBL] [Abstract][Full Text] [Related]
38. Detection of varicella-zoster virus DNA using the polymerase chain reaction in an immunocompromised patient with transverse myelitis secondary to herpes zoster.
Grant AD; Fox JD; Brink NS; Miller RF
Genitourin Med; 1993 Aug; 69(4):273-5. PubMed ID: 7721287
[TBL] [Abstract][Full Text] [Related]
39. Recurrent herpes zoster myelitis treated with human interferon alpha: a case report.
Nakano T; Awaki E; Araga S; Takai H; Inoue K; Takahashi K
Acta Neurol Scand; 1992 May; 85(5):372-5. PubMed ID: 1320320
[TBL] [Abstract][Full Text] [Related]
40. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.
Arvin AM; Wolinsky JS; Kappos L; Morris MI; Reder AT; Tornatore C; Gershon A; Gershon M; Levin MJ; Bezuidenhoudt M; Putzki N
JAMA Neurol; 2015 Jan; 72(1):31-9. PubMed ID: 25419615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
